Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.

Wester Trejo MAC, Floßmann O, Westman KW, Höglund P, Hagen EC, Walsh M, Bruijn JA, Jayne DRW, Bajema IM, Berden AE.

Rheumatology (Oxford). 2019 Jan 1;58(1):103-109. doi: 10.1093/rheumatology/key260.

PMID:
30551161
2.

Anti-plasminogen antibodies in ANCA-associated vasculitis: An optimized anti-plasminogen assay.

Göçeroğlu A, Grenmyr E, Berden AE, Hagen EC, Bunch D, Sommarin Y, Bruijn JA, Bajema IM, Wieslander J.

PLoS One. 2018 Nov 12;13(11):e0207064. doi: 10.1371/journal.pone.0207064. eCollection 2018.

3.

Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus.

Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH, Hartman AL, Probasco JC, Benavides DR, Venkatesan A, Hagen EC, Dittrich D, Stern T, Radzik B, Depew M, Caserta FM, Nyquist P, Kaplan PW, Geocadin RG.

Neurology. 2017 Mar 7;88(10):938-943. doi: 10.1212/WNL.0000000000003690. Epub 2017 Feb 8.

4.

GUIDE, a structured pre-dialysis programme that increases the use of home dialysis.

de Maar JS, de Groot MA, Luik PT, Mui KW, Hagen EC.

Clin Kidney J. 2016 Dec;9(6):826-832. Epub 2016 May 30.

5.

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.

Göçeroğlu A, Berden AE, Fiocco M, Floßmann O, Westman KW, Ferrario F, Gaskin G, Pusey CD, Hagen EC, Noël LH, Rasmussen N, Waldherr R, Walsh M, Bruijn JA, Jayne DR, Bajema IM; European Vasculitis Society (EUVAS).

PLoS One. 2016 Dec 14;11(12):e0165402. doi: 10.1371/journal.pone.0165402. eCollection 2016.

6.

The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis.

Göçeroğlu A, Rahmattulla C, Berden AE, Reinders ME, Wolterbeek R, Steenbergen EJ, Hilbrands LB, Noorlander I, Berger SP, Peutz-Kootstra CJ, Christiaans MH, van Dijk MC, de Joode AA, Goldschmeding R, van Zuilen AD, Harper L, Little MA, Hagen EC, Bruijn JA, Bajema IM.

Transplantation. 2016 Apr;100(4):916-24. doi: 10.1097/TP.0000000000000910.

PMID:
26371598
7.

Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.

Rahmattulla C, Berden AE, Wakker SC, Reinders ME, Hagen EC, Wolterbeek R, Bruijn JA, Bajema IM.

Arthritis Rheumatol. 2015 Dec;67(12):3270-8. doi: 10.1002/art.39317.

8.

Twenty-five years of RENHIS: a history of histopathological studies within EUVAS.

van Daalen E, Ferrario F, Noël LH, Waldherr R, Hagen EC, Bruijn JA, Bajema IM.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i31-6. doi: 10.1093/ndt/gfv035. Review.

PMID:
25805748
9.

Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials.

Rahmattulla C, de Lind van Wijngaarden RA, Berden AE, Hauer HA, Floßmann O, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Wolterbeek R, Göçeroğlu A, Pusey CD, Hagen EC, Bruijn JA, Bajema IM; European Vasculitis Study Group (EUVAS).

Rheumatology (Oxford). 2015 May;54(5):899-907. doi: 10.1093/rheumatology/keu357. Epub 2014 Oct 22.

PMID:
25342376
10.

Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial.

Russcher M, Koch BC, Nagtegaal JE, van Ittersum FJ, Pasker-de Jong PC, Hagen EC, van Dorp WT, Gabreëls B, Wildbergh TX, van der Westerlaken MM, Gaillard CA, Ter Wee PM.

Br J Clin Pharmacol. 2013 Nov;76(5):668-79. doi: 10.1111/bcp.12093.

11.

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA.

Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715. No abstract available.

12.

Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.

Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Höglund P, Merkel PA, Pagnoux C, Rasmussen N, Westman K, Jayne DR; French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS).

Ann Rheum Dis. 2013 Jun;72(6):1003-10. doi: 10.1136/annrheumdis-2012-201750. Epub 2012 Sep 8.

PMID:
22962314
13.

Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital.

Goorhuis A, Debast SB, Dutilh JC, van Kinschot CM, Harmanus C, Cannegieter SC, Hagen EC, Kuijper EJ.

Clin Infect Dis. 2011 Nov;53(9):860-9. doi: 10.1093/cid/cir549. Epub 2011 Sep 13.

PMID:
21914851
14.

Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.

Frazão JM, Messa P, Mellotte GJ, Geiger H, Hagen EC, Quarles LD, Kerr PG, Baños A, Dehmel B, Urena P.

Clin Nephrol. 2011 Sep;76(3):233-43.

PMID:
21888861
15.

Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods.

Linder R, Orth I, Hagen EC, van der Woude FJ, Schmitt WH.

J Rheumatol. 2011 Jun;38(6):1039-47. doi: 10.3899/jrheum.100814. Epub 2011 Feb 15.

PMID:
21324966
16.

Time-resolved spectra of dense plasma focus using spectrometer, streak camera, and CCD combination.

Goldin FJ, Meehan BT, Hagen EC, Wilkins PR.

Rev Sci Instrum. 2010 Oct;81(10):10E531. doi: 10.1063/1.3491207.

PMID:
21034059
17.

Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis.

Berden AE, Nolan SL, Morris HL, Bertina RM, Erasmus DD, Hagen EC, Hayes DP, van Tilburg NH, Bruijn JA, Savage CO, Bajema IM, Hewins P.

J Am Soc Nephrol. 2010 Dec;21(12):2169-79. doi: 10.1681/ASN.2010030274. Epub 2010 Sep 16.

18.

Histopathologic classification of ANCA-associated glomerulonephritis.

Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM.

J Am Soc Nephrol. 2010 Oct;21(10):1628-36. doi: 10.1681/ASN.2010050477. Epub 2010 Jul 8.

19.

Different melatonin rhythms and sleep-wake rhythms in patients on peritoneal dialysis, daytime hemodialysis and nocturnal hemodialysis.

Koch BC, Nagtegaal JE, Hagen EC, Wee PM, Kerkhof GA.

Sleep Med. 2010 Mar;11(3):242-6. doi: 10.1016/j.sleep.2009.04.006. Epub 2009 Jul 10.

PMID:
19596605
20.

The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study).

Koch BC, Nagtegaal JE, Hagen EC, van der Westerlaken MM, Boringa JB, Kerkhof GA, Ter Wee PM.

Br J Clin Pharmacol. 2009 Jan;67(1):68-75. doi: 10.1111/j.1365-2125.2008.03320.x. Epub 2008 Nov 17.

21.

Subjective sleep efficiency of hemodialysis patients.

Koch BC, Nagtegaal JE, Hagen EC, van Dorp WT, Boringa JB, Kerkhof GA, Ter Wee PM.

Clin Nephrol. 2008 Nov;70(5):411-6.

PMID:
19000541
22.

Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: an uncontrolled trial.

Koch BC, Hagen EC, Nagtegaal JE, Boringa JB, Kerkhof GA, Ter Wee PM.

Am J Kidney Dis. 2009 Apr;53(4):658-64. doi: 10.1053/j.ajkd.2008.08.006. Epub 2008 Oct 31.

PMID:
18950916
23.

Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.

Bauer MP, Goorhuis A, Koster T, Numan-Ruberg SC, Hagen EC, Debast SB, Kuijper EJ, van Dissel JT.

Neth J Med. 2008 May;66(5):207-11. Review.

24.

Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known.

de Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW, Mahr AD, Niles JL, de Heer E, Bruijn JA, Bajema IM.

Clin J Am Soc Nephrol. 2008 Jan;3(1):237-52. Epub 2007 Dec 12. Review.

25.

Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis.

Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, van Houwelingen HC, Derksen RH, Berden JH.

Nephrol Dial Transplant. 2008 Jan;23(1):223-30. Epub 2007 Nov 2.

PMID:
17981886
26.

Steroid responsive aortitis.

van Oostrom AJ, Hagen EC, de Klerk JM, Schepens MA, Senden PJ, Landman MA.

Eur Heart J. 2007 Aug;28(16):2005. No abstract available.

PMID:
17698859
27.

Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis.

de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Bruijn JA, Bajema IM, Hagen EC, Pusey CD; EUVAS.

J Am Soc Nephrol. 2007 Jul;18(7):2189-97. Erratum in: J Am Soc Nephrol. 2007 Dec;18(12):3206. Pusey, Charles D [added].

28.

Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.

Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Arthritis Rheum. 2007 Mar;56(3):924-37.

29.

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM.

J Am Soc Nephrol. 2006 Aug;17(8):2264-74. Epub 2006 Jul 6.

30.

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Kidney Int. 2006 Aug;70(4):732-42. Epub 2006 Jul 5.

31.

Henoch-Schönlein purpura presenting as terminal ileitis and complicated by thrombotic microangiopathy.

Al-Toma AA, Brink MA, Hagen EC.

Eur J Intern Med. 2005 Nov;16(7):510-2.

PMID:
16275547
32.

[Lithium, a potentially dangerous drug].

van der Goot B, Hagen EC, Keet IP, Wernand J.

Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1018; author reply 1018-9. Dutch. No abstract available.

PMID:
15903048
33.

A case of multiple aortic thrombi.

Braam RL, Gaillard CA, Ike BW, Hagen EC.

Neth J Med. 2004 Sep;62(8):304, 306. No abstract available.

PMID:
15588073
34.

Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.

Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suárez LF, van der Woude FJ; European Vasculitis Study Group.

Kidney Int. 2004 Apr;65(4):1440-8.

35.

Use of ANCA in diagnosis.

Hagen EC, van Gurp EA.

Arthritis Care Res. 2000 Dec;13(6):341-2. No abstract available.

PMID:
14635308
36.

Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist.

Grootscholten C, Ligtenberg G, Derksen RH, Schreurs KM, de Glas-Vos JW, Hagen EC, van den Wall Bake AW, Huizinga TW, van den Hoogen FH, Bijl M, van Houwelingen JC, Snoek FJ, Berden JH.

Qual Life Res. 2003 Sep;12(6):635-44.

PMID:
14516173
37.

Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.

Savige J, Dimech W, Fritzler M, Goeken J, Hagen EC, Jennette JC, McEvoy R, Pusey C, Pollock W, Trevisin M, Wiik A, Wong R; International Group for Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).

Am J Clin Pathol. 2003 Sep;120(3):312-8. Review.

PMID:
14502794
38.

Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure.

Prinsen BH, Rabelink TJ, Beutler JJ, Kaysen GA, De Boer J, Boer WH, Hagen EC, Berger R, De Sain-Van Der Velden MG.

Kidney Int. 2003 Oct;64(4):1495-504.

39.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group.

N Engl J Med. 2003 Jul 3;349(1):36-44.

40.

Renal mRNA levels as prognostic tools in kidney diseases.

Eikmans M, Baelde HJ, Hagen EC, Paul LC, Eilers PH, De Heer E, Bruijn JA.

J Am Soc Nephrol. 2003 Apr;14(4):899-907.

41.

An index for renal outcome in ANCA-associated glomerulonephritis.

Vergunst CE, van Gurp E, Hagen EC, van Houwelingen HC, Hauer HA, Noël LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, Bajema IM; EC/BCR Project for ANCA-Assay Standardisation.

Am J Kidney Dis. 2003 Mar;41(3):532-8.

PMID:
12612975
42.

Glomerulonephritis in the vasculitides: advances in immunopathology.

Hauer HA, Hagen EC, de Heer E, Bruijn JA, Bajema IM.

Curr Opin Rheumatol. 2003 Jan;15(1):17-21. Review.

PMID:
12496505
43.

Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients.

Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; European Vasculitis Study Group (EUVAS).

Kidney Int. 2002 Nov;62(5):1732-42.

44.

Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies.

Hauer HA, Bajema IM, Hagen EC, Noël LH, Ferrario F, Waldherr R, van Houwelingen HC, Lesavre P, Sinico RA, van der Woude F, Gaskin G, Verburgh CA, de Heer E, Bruijn JA.

Nephrol Dial Transplant. 2002 Apr;17(4):587-96.

PMID:
11917050
45.

Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; European Vasculitis Study Group (EUVAS).

Kidney Int. 2002 Jan;61(1):80-9.

46.

Colocalization of ANCA-antigens and fibrinoid necrosis in ANCA-associated vasculitis.

Bajema IM, Hagen EC, de Heer E, van der Woude FJ, Bruijn JA.

Kidney Int. 2001 Nov;60(5):2025-30.

47.

Immunopathological aspects of systemic vasculitis.

Bajema IM, Hagen EC, Ferrario F, de Heer E, Bruijn JA.

Springer Semin Immunopathol. 2001;23(3):253-65. Review. No abstract available.

PMID:
11591101
48.

Graft surveillance: venous pressure, access flow, or the combination?

Smits JH, van der Linden J, Hagen EC, Modderkolk-Cammeraat EC, Feith GW, Koomans HA, van den Dorpel MA, Blankestijn PJ.

Kidney Int. 2001 Apr;59(4):1551-8.

49.

Distribution of renal lesions in idiopathic systemic vasculitis: A three-dimensional analysis of 87 glomeruli.

Hauer HA, Bajema IM, de Heer E, Hermans J, Hagen EC, Bruijn JA.

Am J Kidney Dis. 2000 Aug;36(2):257-65.

PMID:
10922303
50.

Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis.

Bajema IM, Hagen EC, Hermans J, Noël LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA.

Kidney Int. 1999 Nov;56(5):1751-8.

Supplemental Content

Loading ...
Support Center